Amendia acquired SpineSelect’s assets, broadening Amendia’s product portfolio.
Anika Therapeutics submitted an investigational device exemption with the FDA to conduct a phase III clinical trial.
Ankasa Regenerative Therapeutics received $8.5 million in the first portion of a $17 million Series A round of financing round.
Bacterin signed a new group purchasing agreement with Premier.
Bacterin also signed a three-year agreement with Yankee Alliance.
The Joint Commission granted Bioness accreditation and the Gold Seal of Approval for healthcare quality and safety for complying with its performance standards.
Blue Belt Technologies partnered with SurgCenter Development.
DJO Global acquired assets from Zimmer and Biomet on the heels of the two companies finalizing a landmark merger.
Ellipse Technologies’ PRECICE limb length discrepancy technology has now been used to treat 2,000 patients.
Hill-Rom bought Welch Allyn for $2.05 billion, resulting in financial benefits for both medical device and technology companies.
Histogenics appointed Jonathan Lieber as CFO, effective July 2.
IlluminOss Medical announced that the first two U.S. patients have been treated with the IlluminOss System, its proprietary bone stabilization technology.
InVivo Therapeutics received a United States patent for the methods and treatment covering their investigational Neuro-Spinal Scaffold for spinal cord injury treatment.
K2M insider John P. Kostuik, MD, sold 46,957 shares of the company’s stock in a transaction on June 18.
Mazor Robotics reported the 50th Renaissance system was sold in the United States.
Also, the NeuroInstitut Oliver-Ayats Barcelona in Spain and a hospital in Indiana placed orders for Mazor’s Renaissance robotic spine surgery system.
Medtronic’s Infuse Bone Graft is once again the center of a lawsuit.
MSD’s Simponi treatment for patients with non-radiographic axial spondyloarthritis received the CE Mark from the European Commission.
Pathway Neurosystems, a Boston-based medical device company, revealed expansion plans into France to make its mark in the European market.
SIGNUS has devised a new device to opitmize fusion results — ASCOT offers physicians reliability and flexibility in performing procedures.
Smith & Nephew plans to acquire Zimmer’s unicondylar knee system in the United States market.
The StabiLink MIS Interlaminar Spinal Fixation System from Southern Spine was recognized at the 18th Annual Medical Design Excellence Awards competition.
TissueGen, developer of ELUTE fiver, a biodegradable fiber format for advanced drug delivery, appointed Jennifer Seifert, PhD, as the senior scientist.
The Musculoskeletal Clinical Regulatory Advisers was instrumental in securing premarket approval from the FDA for the VertiFlex Superion Interspinous Spacer for patients with spinal stenosis.
A new peer-reviewed paper was published over-viewing the clinical results for the VariLift Interbody Fusion System from Wenzel Spine, which found that the system demonstrated effectiveness.
The Los Angeles County Superior Court ruled on Wright Medical Technology’s Profemur hip implant lawsuit — the jury found the implant didn’t have a defective design, but there were defects in the implant’s manufacturing.
More than a year after announcing plans to merge, the $14 billion Zimmer-Biomet combination is complete.
More articles on devices:
SIGNUS develops ASCOT for spinal fusion — 7 things to know
Tyber Medical launches lateral retractor system — 5 things to know
Simponi receives CE mark — 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
